Lord Patel (CB)

My Lords, does the Minister agree that we are more likely to succeed in having international regulation for AI if the regulations are based not on a single set of regulations for all algorithms but on

My Lords, if our intention is to increase the diagnosis rate of early dementia, normally what we would do is to find a screening test that would identify people at risk of any disease. There is one ca

My Lords, several trials are assessing the use of AI for prostate cancer screening and diagnostics, as well as testing the accuracy of digital imaging and histological imaging of biopsies to understan

My Lords, going back to the question about access to compassionate medicine, as I understand, the Minister just stated that medicines that are not yet authorised or licensed can be issued if companies

My Lords, we lead in genomic science and infrastructure by having established seven hubs for genomic testing. Despite this, we fall behind in testing for liquid biopsies of DNA and for circulating DNA

I suggest that the Minister looks again at the evidence produced recently by Novo Nordisk, the manufacturer of Wegovy drugs for obesity reduction, to see whether what was just said still applies in th